Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 13/20 | 0.58 |
| ▸ | GGPS1 | O95749 | 7/20 | 0.58 |
| ▸ | SMPD1 | P17405 | 5/20 | 0.52 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.52 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL60846 | 1.00 | FDPS (0.58) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL7188409 | 1.00 | FDPS (0.58) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL2695072 | 1.00 | FDPS (0.58) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL1044717 | 1.00 | FDPS (0.58) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL62052 | 1.00 | FDPS (0.58) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL418810 | 1.00 | FDPS (0.58) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL2693656 | 1.00 | FDPS (0.58) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL632447 | 1.00 | FDPS (0.58) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL905578 | 1.00 | FDPS (0.58) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL60424 | 1.00 | FDPS (0.58) | FDPSGGPS1SMPD1LPAR1LPAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3586142-B1 | DETECTION OF MEMBRANE PROTEINS | UNIV OXFORD INNOVATION LTD (GB) | 2024-12-25 | — | — | EP | disclosed |
| US-10955421-B2 | Detection of membrane proteins | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2021-03-23 | — | — | US | disclosed |
| US-20200240997-A1 | DETECTION OF MEMBRANE PROTEINS | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2020-07-30 | — | — | US | disclosed |
| WO-2018154318-A1 | DETECTION OF MEMBRANE PROTEINS | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2018-08-30 | — | — | WO | disclosed |
| EP-1550669-B1 | Refolded membrane protein in monodisperse form | PHASYS GMBH M (DE) | 2008-08-06 | — | — | EP | disclosed |
| US-20070031926-A1 | Refolded membrane protein in monodisperse form | M-PHASYS GMBH (DE) | 2007-02-08 | — | — | US | disclosed |
| EP-1704163-A1 | REFOLDED MEMBRANE PROTEIN IN MONODISPERSE FORM | M-Phasys GmbH (DE) | 2006-09-27 | — | — | EP | disclosed |
| EP-1550669-A1 | Refolded membrane protein in monodisperse form | M-Phasys GmbH (DE) | 2005-07-06 | — | — | EP | disclosed |
| WO-2005058942-A1 | REFOLDED MEMBRANE PROTEIN IN MONODISPERSE FORM | M-PHASYS GMBH (DE) | 2005-06-30 | — | — | WO | disclosed |
| EP-1544209-A1 | Refolded membrane protein in monodisperse form | M-Phasys GmbH (DE) | 2005-06-22 | — | — | EP | disclosed |
| US-20050130260-A1 | Refolded membrane protein in monodisperse form | M-PHASYS GMBH (DE) | 2005-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200240997-A1 | DETECTION OF MEMBRANE PROTEINS | CETP, VAPA, PCTP | FDPS 642/4885GGPS1 893/4885SMPD1 77/4885 |
| US-10955421-B2 | Detection of membrane proteins | CETP, VAPA, PCTP | FDPS 642/4885GGPS1 893/4885SMPD1 77/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.